Company Active PRIVATE-LIMITED-GUARANT-NSC

Company profile

Beatson Institute For Cancer Research

UK company SC084170, incorporated on 3 August 1983.

Home

Beatson Institute For Cancer Research is a UK company with status active founded in 1983.

Company number

SC084170

Incorporated

3 Aug 1983

Companies House status

Active

Company identity

Founded / incorporated

3 August 1983

Company number SC084170

Verify at Companies House

Legal name

BEATSON INSTITUTE FOR CANCER RESEARCH

Company type

PRIVATE-LIMITED-GUARANT-NSC

Region

Unknown

Registered address

Unknown

Insolvency history

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller Controls 1

Company Active PRIVATE-LIMITED-GUARANT-NSC

Beatson Institute For Cancer Research

CRN SC084170

Direct and ultimate controller Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Cancer Research UK

CRN 04325234

Company events

Reference milestones and recent Companies House filing stream events.

2 events

25 Aug

2026

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzU0MDU5MDgxNmFkaXF6a2N4 | Paper/PDF filed

Published 26 Aug 2026 22:56

03 Aug

1983

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2023

Funded years

2023

Age at first award

39 years

Projects

2023 Collaborative R&D

Project LIPICARE - Combining nanotechnology, gene editing and CAR-T to create a 'one-shot' cure for cancer

1 Feb 2023 to 31 Jan 2026

Awarded

£0

Total cost £0

LIPICARE is a bold and ambitious project conceived by a consortium of the UK's leading scientists in the field of gene and cancer therapy. We aim to combine advances in nanotechnology, cell therapy and gene editing to create a one-shot cure for cancer. Chimeric Antigen Receptor -- T cell (CAR-T) cancer immunotherapy involves genetically manipulating immun...

Product types

Collaborative R&D